SCHEMBL6713652

SCHEMBL6713652

O=C(Cc1ccc(Cl)cc1Cl)Nc1cccc2cc(C(=O)Nc3ccc(Br)cc3-c3noc(=O)[nH]3)[nH]c12

nearest known ligand 0.45

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
GRIK1 P39086 1/20 0.45
GALR3 O60755 1/20 0.37
NR2F2 P24468 1/20 0.37
NHERF1 O14745 1/20 0.35
PLCG2 P16885 1/20 0.35
ALDH1A1 P00352 2/20 0.34
LMNA P02545 2/20 0.34
HPGD P15428 2/20 0.34
PARP14 Q460N5 1/20 0.34
TRPV1 Q8NER1 1/20 0.34
KDM4E B2RXH2 1/20 0.34
MEN1 O00255 2/20 0.33
KMT2A Q03164 2/20 0.33
F11 P03951 1/20 0.33
MAPT P10636 1/20 0.33
APOBEC3G Q9HC16 1/20 0.33
GPR35 Q9HC97 2/20 0.33
PTK2B Q14289 1/20 0.33
BACE1 P56817 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6713233 0.95 GRIK1 (0.41) GRIK1GALR3NR2F2NHERF1PLCG2
SCHEMBL6709037 0.92 PARP14 (0.42) GRIK1NHERF1ALDH1A1PARP14MEN1
SCHEMBL6707655 0.90 GRIK1 (0.45) GRIK1PLCG2ALDH1A1LMNAPARP14
SCHEMBL6709181 0.89 GRIK1 (0.44) GRIK1PLCG2ALDH1A1LMNAMEN1
SCHEMBL6707749 0.89 GRIK1 (0.42) GRIK1PLCG2LMNAMEN1KMT2A
SCHEMBL6710278 0.89 PARP14 (0.43) GRIK1NHERF1PLCG2ALDH1A1LMNA
SCHEMBL6709095 0.89 GRIK1 (0.37) GRIK1GALR3NR2F2NHERF1PLCG2
SCHEMBL6712138 0.87 PARP14 (0.43) GRIK1ALDH1A1LMNAPARP14TRPV1
SCHEMBL6712548 0.87 KMT2A (0.48) GRIK1ALDH1A1LMNAHPGDKDM4E
SCHEMBL6707664 0.86 NSD2 (0.41) GRIK1ALDH1A1LMNAPARP14MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142981-A1 Antibacterial benzoic acid derivatives PHARMACIA & UPJOHN COMPANY 2004-07-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142981-A1 Antibacterial benzoic acid derivatives GABRD, PHB1, GABBR1 GRIK1 3885/4885GALR3 4874/4885NR2F2 1512/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.